Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01
Expanded Program on Immunization
Malaria
RTS
S/AS01E
hepatitis B
long-term immunogenicity
safety
vaccine
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
02 06 2020
02 06 2020
Historique:
pubmed:
18
1
2020
medline:
22
6
2021
entrez:
18
1
2020
Statut:
ppublish
Résumé
RTS,S/AS01
Identifiants
pubmed: 31951771
doi: 10.1080/21645515.2019.1695457
pmc: PMC7482624
doi:
Substances chimiques
Diphtheria-Tetanus-Pertussis Vaccine
0
Diphtheria-Tetanus-acellular Pertussis Vaccines
0
Haemophilus Vaccines
0
Hepatitis B Vaccines
0
Malaria Vaccines
0
Poliovirus Vaccine, Inactivated
0
Vaccines, Combined
0
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1464-1470Références
N Engl J Med. 2012 Dec 13;367(24):2284-95
pubmed: 23136909
Clin Infect Dis. 2011 Jul 1;53(1):68-75
pubmed: 21653306
Clin Infect Dis. 2007 May 1;44(9):1170-2
pubmed: 17407034
Wkly Epidemiol Rec. 2016 Jan 4;91(4):33-51
pubmed: 26829826
Hum Vaccin Immunother. 2018 Jun 3;14(6):1489-1500
pubmed: 29630438
Postgrad Med J. 1987;63 Suppl 2:51-6
pubmed: 2446303
J Med Virol. 1985 May;16(1):89-96
pubmed: 2413167
Infection. 1989 Mar-Apr;17(2):70-6
pubmed: 2714860
Lancet Infect Dis. 2011 Oct;11(10):741-9
pubmed: 21782519